These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 32664792)
1. Sliding Scoring of the Glasgow Outcome Scale-Extended as Primary Outcome in Traumatic Brain Injury Trials. Yeatts SD; Martin RH; Meurer W; Silbergleit R; Rockswold GL; Barsan WG; Korley FK; Wright DW; Gajewski BJ J Neurotrauma; 2020 Dec; 37(24):2674-2679. PubMed ID: 32664792 [TBL] [Abstract][Full Text] [Related]
2. Selection of a statistical analysis method for the Glasgow Outcome Scale-Extended endpoint for estimating the probability of favorable outcome in future severe TBI clinical trials. Wang Y; Yeatts SD; Martin RH; Silbergleit R; Rockswold GL; Barsan WG; Korley FK; Rockswold S; Gajewski BJ Stat Med; 2023 Nov; 42(25):4582-4601. PubMed ID: 37599009 [TBL] [Abstract][Full Text] [Related]
3. Glasgow Outcome Scale Measures and Impact on Analysis and Results of a Randomized Clinical Trial of Severe Traumatic Brain Injury. Yamal JM; Hannay HJ; Gopinath S; Aisiku IP; Benoit JS; Robertson CS J Neurotrauma; 2019 Sep; 36(17):2484-2492. PubMed ID: 30973053 [TBL] [Abstract][Full Text] [Related]
4. Comparative study of outcome measures and analysis methods for traumatic brain injury trials. Alali AS; Vavrek D; Barber J; Dikmen S; Nathens AB; Temkin NR J Neurotrauma; 2015 Apr; 32(8):581-9. PubMed ID: 25317951 [TBL] [Abstract][Full Text] [Related]
5. A simulation study evaluating approaches to the analysis of ordinal outcome data in randomized controlled trials in traumatic brain injury: results from the IMPACT Project. McHugh GS; Butcher I; Steyerberg EW; Marmarou A; Lu J; Lingsma HF; Weir J; Maas AI; Murray GD Clin Trials; 2010 Feb; 7(1):44-57. PubMed ID: 20156956 [TBL] [Abstract][Full Text] [Related]
6. The added value of ordinal analysis in clinical trials: an example in traumatic brain injury. Roozenbeek B; Lingsma HF; Perel P; Edwards P; Roberts I; Murray GD; Maas AI; Steyerberg EW; ; Crit Care; 2011; 15(3):R127. PubMed ID: 21586148 [TBL] [Abstract][Full Text] [Related]
8. Simplifying the use of prognostic information in traumatic brain injury. Part 1: The GCS-Pupils score: an extended index of clinical severity. Brennan PM; Murray GD; Teasdale GM J Neurosurg; 2018 Jun; 128(6):1612-1620. PubMed ID: 29631516 [TBL] [Abstract][Full Text] [Related]
9. Does the sliding dichotomy result in higher powered clinical trials for stroke and traumatic brain injury research? Price M; Hertzberg V; Wright DW Clin Trials; 2013; 10(6):924-34. PubMed ID: 23027647 [TBL] [Abstract][Full Text] [Related]
10. Longitudinal description of the glasgow outcome scale-extended for individuals in the traumatic brain injury model systems national database: a National Institute on Disability and Rehabilitation Research traumatic brain injury model systems study. Pretz CR; Dams-O'Connor K Arch Phys Med Rehabil; 2013 Dec; 94(12):2486-2493. PubMed ID: 23838239 [TBL] [Abstract][Full Text] [Related]
11. Does the extended Glasgow Outcome Scale add value to the conventional Glasgow Outcome Scale? Weir J; Steyerberg EW; Butcher I; Lu J; Lingsma HF; McHugh GS; Roozenbeek B; Maas AI; Murray GD J Neurotrauma; 2012 Jan; 29(1):53-8. PubMed ID: 22026476 [TBL] [Abstract][Full Text] [Related]
12. Design and analysis of phase III trials with ordered outcome scales: the concept of the sliding dichotomy. Murray GD; Barer D; Choi S; Fernandes H; Gregson B; Lees KR; Maas AI; Marmarou A; Mendelow AD; Steyerberg EW; Taylor GS; Teasdale GM; Weir CJ J Neurotrauma; 2005 May; 22(5):511-7. PubMed ID: 15892597 [TBL] [Abstract][Full Text] [Related]
13. Simplifying the use of prognostic information in traumatic brain injury. Part 2: Graphical presentation of probabilities. Murray GD; Brennan PM; Teasdale GM J Neurosurg; 2018 Jun; 128(6):1621-1634. PubMed ID: 29631517 [TBL] [Abstract][Full Text] [Related]
14. Serum biomarkers as predictors of long-term outcome in severe traumatic brain injury: analysis from a randomized placebo-controlled Phase II clinical trial. Raheja A; Sinha S; Samson N; Bhoi S; Subramanian A; Sharma P; Sharma BS J Neurosurg; 2016 Sep; 125(3):631-41. PubMed ID: 26722854 [TBL] [Abstract][Full Text] [Related]